Aquestive Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 62.8%.

Top 25 shareholders own 35.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	Bratton Capital Management, L.P.	9,810,958	US$33.0m	0%	100.0%
6.1%	VR Adviser, LLC	5,555,555	US$18.7m	0%	1.15%
4.31%	Armistice Capital LLC	3,924,000	US$13.2m	-18.3%	0.37%
2.08%	The Vanguard Group, Inc.	1,889,053	US$6.4m	11.2%	no data
1.59%	Franklin Resources, Inc.	1,451,200	US$4.9m	0%	no data
1.4%	Renaissance Technologies LLC	1,271,500	US$4.3m	12.6%	0.01%
1.08%	Alexander Schobel	984,476	US$3.3m	0.16%	no data
0.93%	Essex Investment Management Company, LLC	846,167	US$2.8m	0%	0.59%
0.93%	Daniel Barber	845,364	US$2.8m	31.8%	no data
0.7%	Keith Kendall	637,149	US$2.1m	0%	no data
0.65%	Vahanian & Associates Financial Planning Inc	591,608	US$2.0m	-18.1%	8.05%
0.6%	Acadian Asset Management LLC	550,484	US$1.9m	0%	0.01%
0.54%	Geode Capital Management, LLC	494,902	US$1.7m	8.4%	no data
0.53%	BlackRock, Inc.	478,019	US$1.6m	-0.41%	no data
0.47%	Bracebridge Capital, LLC	428,571	US$1.4m	0%	1.46%
0.34%	Lori Braender	313,231	US$1.1m	65.9%	no data
0.32%	Marshall Wace LLP	288,884	US$972.1k	-7.05%	no data
0.29%	Carl Kraus	262,500	US$883.3k	75%	no data
0.29%	Connor, Clark & Lunn Investment Management Ltd.	261,592	US$880.3k	5.55%	no data
0.28%	Douglas Bratton	255,153	US$858.6k	0%	no data
0.27%	Legato Capital Management, LLC	248,503	US$836.2k	-27%	0.12%
0.27%	A. Toth	248,295	US$835.5k	77.4%	no data
0.27%	Stephen Wargacki	247,963	US$834.4k	74.7%	no data
0.27%	Latash Investments, LLC	243,134	US$818.2k	0%	0.55%
0.26%	Peter Boyd	237,628	US$799.6k	49%	no data